4
Changes in Ownership
Taysha Gene Therapies, Inc. Filed Acc 0001209191-22-041455
CMO and Head of R&D sold 12,861 shares at an average $3.70 ($47,650)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| PRASAD SUYASH CMO and Head of R&D | 2022-07-05 | Sale | −3,905 | $3.51 | $13,707 | 539,545 | D |
| PRASAD SUYASH CMO and Head of R&D | 2022-07-06 | Sale | −8,956 | $3.79 | $33,943 | 530,589 | D |
| Open-market sales · 12,861 sh · avg $3.70 · $47,650 | |||||||
Loading xslF345X03/doc4.xml…